{"schema_version":"secwatch.filing_event.v1","accession":"0001185185-23-000976","form_type":"8-K","ticker":"STEX","cik":"0001530766","company_name":"Streamex Corp.","filed_at":"2023-09-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.217057+00:00","generated_at":"2026-06-10T16:14:55.878820+00:00","sec_items":["1.01","1.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"BioSig enters $30M ATM sales agreement with Ascendiant; terminates Cantor facility","bullets":["New ATM with Ascendiant Capital Markets for up to $30M of common stock; 3% commission.","Terminated prior Cantor Fitzgerald ATM agreement effective Sept 15, 2023.","Under Cantor, sold 218,810 shares at avg $0.5463 between Aug 29 and Sept 6, 2023.","No termination penalties paid to Cantor.","Sales under new ATM may be made at the Company's discretion; no minimum obligation."],"urls":{"canonical":"https://secwatch.observer/filing/0001185185-23-000976","json":"https://secwatch.observer/filing/0001185185-23-000976.json","markdown":"https://secwatch.observer/filing/0001185185-23-000976.md","text":"https://secwatch.observer/filing/0001185185-23-000976.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000976/0001185185-23-000976-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000976/biosig20230915_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T16:14:55.878820+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"25fa706950687fb21bdd7fc10ca8952ebc38bb52","claim":"Streamex Corp. terminated Controlled Equity Offering SM Sales Agreement with Cantor Fitzgerald & Co. (effective 2023-09-15).","evidence_excerpt":"On September 15, 2023, the Company delivered written notice to Cantor to terminate the Cantor Agreement, effective September 15, 2023, pursuant to Section 12(b) of the Cantor Agreement.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000976/0001185185-23-000976-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Cantor Fitzgerald & Co."},{"label":"Effective","value":"2023-09-15"}],"fact_type":"material_agreement"},{"claim_id":"9b1b6022febe8b6f1177e3f2a2dadbf990d05aa9","claim":"Streamex Corp. entered into Sales Agreement with Ascendiant Capital Markets, LLC (effective 2023-09-15).","evidence_excerpt":"On September 15, 2023, BioSig Technologies, Inc. (the “Company”) entered into an At-The-Market Issuance Sales Agreement (the “Sales Agreement”) with Ascendiant Capital Markets, LLC, to act as the Company’s sales agent or principal (“Agent”), with respect to the issuance and sale of the Company’s shares of common stock, par value $0.001 per share (the “Shares”), from time to time in an at the market offering.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518523000976/0001185185-23-000976-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Ascendiant Capital Markets, LLC"},{"label":"Effective","value":"2023-09-15"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}